FDA approves last-resort drug for a certain type of fast-moving leukemia. Awful side effects, but gives 36% of treated patients 8 months of remission. Which means, horribly, that 64% so not benefit.

https://www.usnews.com/news/business/articles...f-leukemia

We need Kevetrin ASAP.